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A B S T R A C T
Benzimidazoles (BZs) remain amongst the most widely used anthelmintic drug classes against gastro-intestinal
nematode infections, although their eﬃcacy is increasingly compromised by resistance. The primary underlying
mechanisms for BZ resistance are single-nucleotide polymorphisms (SNPs) in the isotype 1 β-tubulin gene
causing the substitutions F167Y, E198A or F200Y. However, resistance is believed to be multi-genic and previous
studies have shown that isolates carrying 90–100% F200Y can vary considerably in their resistance level in the
egg hatch assay (EHA). Cytochrome P450 monooxygenases (CYPs) are associated with drug resistance in
mammals and arthropods and have been considered as mediators of anthelmintic resistance. In Caenorhabditis
elegans, several members of the CYP34/35 and CYP31 families are BZ and/or xenobiotic inducible and thia-
bendazole (TBZ) is metabolised by CYP35D1. Here, expression of all 5 CYPs closely related to the C. elegans
CYP34/35 and CYP31 families was investigated in fourth-stage larvae of two susceptible and three BZ-resistant
Haemonchus contortus isolates following in vitro exposure to TBZ for 3 and 6 h using real-time RT-PCR. The
resistance status of all isolates was determined using EHAs and quantiﬁcation of resistance-associated β-tubulin
SNPs using pyrosequencing. While none of the CYPs was TBZ inducible, constitutive expression of CYP34/35
family member HCOI100383400 was signiﬁcantly 2.4–3.7-fold higher in the multi-drug resistant WR isolate
with the strongest BZ resistance phenotype compared to susceptible and intermediate-level BZ-resistant isolates.
Although this increase is only moderate, HCOI100383400 might still be involved in high-level BZ resistance by
further decreasing susceptibility in isolates already carrying 100% of a β-tubulin SNP causing BZ resistance.
Lower transcript levels were observed for all CYPs in the intermediately resistant IRE isolate in comparison to the
susceptible HcH isolate, which, except for CYP HCOI01579500, were statistically non-signiﬁcant. This suggests
that none of the investigated CYPs may contribute to protection against TBZ in this particular isolate.
1. Introduction
In small ruminants, Haemonchus contortus is one of the most pa-
thogenic gastrointestinal nematodes and infections with this parasite
cause considerable economic losses (Perry et al., 2002; Peter and
Chandrawathani, 2005). Treatment of H. contortus and other trichos-
trongyloids has become increasingly diﬃcult due to the emergence of
anthelmintic resistance, particularly in countries that heavily relied on
use of anthelmintics in livestock production. Despite intensive research,
anthelmintic resistance mechanisms are not fully understood yet. Re-
cently, a study reported insuﬃcient activity of the benzimidazole (BZ)
albendazole against human Ascaris lumbricoides infections (Krücken
et al., 2017).
Thiabendazole (TBZ) belongs to the class of benzimidazole (BZ)
anthelmintics which have been in veterinary use against nematode in-
fection since the 1960s. Resistance to BZs has been reported to emerge
through single nucleotide-polymorphisms (SNPs) in the isotype 1 β-
tubulin gene in codons 167, 198 and 200 in a number of trichos-
trongyloid nematodes (Grant and Mascord, 1996; Elard and Humbert,
1999; von Samson-Himmelstjerna et al., 2007; Skuce et al., 2010;
Demeler et al., 2013; Ramünke et al., 2016) including H. contortus (Kwa
et al., 1994; Prichard, 2001; Ghisi et al., 2007). However, no such SNPs
in potential BZ target sites could be identiﬁed in the recent report on
insuﬃcient albendazole eﬃcacy in A. lumbricoides (Krücken et al.,
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In addition to changes in the BZ target sites, non-target related al-
terations have been considered to be involved in anthelmintic re-
sistance. In particular, drug eﬄux pumps, such as P-glycoproteins
(Pgps), have also been addressed as possible mediators of anthelmintic
resistance (Prichard, 2001; Janssen et al., 2013, 2015; Kotze et al.,
2014; Kaschny et al., 2015) – particularly against the macrocyclic lac-
tones where no target-site changes have been associated with re-
sistance. Regarding BZs, selection at the pgp-2 locus in BZ-selected H.
contortus has been described (Blackhall et al., 2008) and AlGusbi et al.
(2014) have shown that the Pgp inhibitor verapamil potentiates the
eﬀects of TBZ on larval stages of BZ-susceptible and -resistant Cooperia
oncophora and Ostertagia ostertagi leading to complete impairment of
larval development. However, no activation of the rhodamine 123
(Rh123) binding site of Pgps and hence no increased eﬄux of Rh123
has been observed in eggs of a resistant H. contortus isolate following
incubation with TBZ or albendazole while most macrocyclic lactones
stimulated Pgp activity as revealed by signiﬁcantly elevated eﬄux of
rhodamine 123 (Kerboeuf and Guegnard, 2011). It is possible that BZs
ﬁrst need to undergo biochemical modiﬁcations to render them better
substrates for eﬄux pumps. Moreover, in silico analysis of the binding
properties of Pgp-1 of the free-living nematode C. elegans has predicted
binding sites for TBZ and triclabendazole, though with less binding
energy than drugs belonging to other classes of anthelmintics (David
et al., 2016).
In recent years, the possibility of resistance via phase I (modifying)
and phase II (conjugating) drug-metabolising enzymes and phase III
transporters has received increasing attention. Regarding phase I, the
largest group of drug-metabolising enzymes, the cytochrome P450
monooxygenases (CYPs), are known to be responsible for the bio-
transformation of a vast number of xenobiotics in mammals and insects
and their association with insecticide and cancer drug resistance is well
established (Rochat, 2005; David et al., 2013).
For a long time, it was assumed that CYPs exhibit no or very low
activities in nematodes (Barrett, 1998). However, this general as-
sumption has been weakened by a number of reports and attention
devoted to CYPs is gradually increasing. The genome of C. elegans en-
codes more than 80 CYP proteins and several of these, in particular
members of the family CYP35, have been shown to be inducible by
xenobiotics (Menzel et al., 2001, 2005). Increased expression of
cyp35C1, cyp35A5 and cyp35A2 mRNAs has been reported in C. elegans
upon albendazole exposure (Laing et al., 2010) and recently TBZ has
been shown to induce cyp35A3, cyp35A5, cyp35C1 and cyp35D1 (Jones
et al., 2013) and to be metabolised by CYP35D1 in C. elegans (Jones
et al., 2015). Other CYP families that are inducible by xenobiotics are
CYP34, CYP31 and CYP33 (Menzel et al., 2001).
In parasitic nematodes, studies on the xenobiotic response to BZs
have progressed less far and focused mainly on H. contortus. One of the
ﬁrst reports on CYP activity was provided by Kotze (1997) using mi-
crosomal preparations of H. contortus. Consistent with phase I followed
by phase II metabolism, ex vivo and in vivo studies have furthermore
shown that in this parasite albendazole and fenbendazole are metabo-
lised to albendazole- and fenbendazole-sulfoxide (Cvilink et al., 2008;
Munguia et al., 2015). Also corroborating the hypothesis of CYP-
mediated BZ resistance in gastro-intestinal nematodes, eggs and larvae
of C. oncophora and O. ostertagi isolates with diﬀering BZ susceptibility
have been shown to become more susceptible to TBZ in the presence of
the CYP inhibitor piperonyl butoxide (AlGusbi et al., 2014).
The CYP superfamily of H. contortus has recently been described in
detail by Laing et al. (2015). They found that the CYP superfamily
encoded in the H. contortus genome is considerably smaller than that of
C. elegans and apparently lacks the extensive duplication of genes with
function in metabolism of exogenous substrates. However, they iden-
tiﬁed four H. contortus CYPs that form a sister family to the xenobiotic-
inducible C. elegans CYP families CYP34 and CYP35 (each with 10
members in C. elegans). This family will be designated as CYP34/35
family in the following. In C. elegans, one member of the CYP35 family,
CYP35D1, has been shown to be inducible by TBZ and to contribute to
detoxiﬁcation of this anthelmintic (Jones et al., 2013, 2015). The H.
contortus CYP34/35 family has apparently evolved through relatively
recent gene duplications since HCOI01928800a and HCOI01928800b
are located directly adjacent to each other on scaﬀold_930 in the H.
contortus genome while HCOI100383700 and HCOI100383400 are se-
parated by only two unrelated genes on scaﬀold_1500 (Laing et al.,
2015). Other xenobiotic-inducible C. elegans CYP families have either
no (CYP33) or only one gene (CYP31) in H. contortus (HCOI01579500)
that has a corresponding position in the phylogenetic tree (see Fig. 3 in
(Laing et al., 2015)).
Since CYP31A and CYP35D1 have been shown to be xenobiotic- and
TBZ-inducible, respectively, and the latter was able to use the drug as
substrate, this study aimed to investigate the expression patterns of the
above mentioned, most closely related H. contortus CYPs in the fourth-
stage larvae (L4) following in vitro exposure to TBZ using qRT-PCR. In
order to determine any potential eﬀects of unspeciﬁc (CYP-mediated)
and speciﬁc (β-tubulin-mediated) resistance mechanisms, the current
phenotypic and target-site related genetic level of resistance of ﬁve H.
contortus isolates was determined by egg hatch assays (EHA) and pyr-
osequencing, respectively. For all three approaches, material from the
same parasite passage was used.
2. Materials and methods
2.1. Parasites
Five isolates of H. contortus with diﬀering susceptibility to BZs and
other anthelmintics were incorporated in this study.
i) H.c Hannover (HcH, MHco9): susceptible to all anthelmintics.
ii) CAVR (MHco10) (Chiswick-Avermectin-Resistant): highly iver-
mectin (IVM) resistant, albeit BZ susceptible.
iii) IRE (inbred-resistant-Edinburgh; MHco5): highly IVM resistant;
partially BZ resistant.
iv) TBZ (Thiabendazole): TBZ resistant; was originally obtained by
Bayer Animal Health
v) WR (White River; MHco4): highly IVM and BZ resistant; moderately
levamisole resistant
All isolates have been maintained at the Institute for Parasitology
and Tropical Veterinary Medicine of the Freie Universität in Berlin for
several years. Resistant isolates were regularly challenged by treatment
of infected animals with the respective anthelmintic. All animal ex-
periments were in agreement with the European directive 2010/63/EU
and the German law (“Tierschutzgesetz”) and were approved by the
responsible local authorities (LAGeSo Berlin) under the reference
number L0088/10. Individual sheep were infected with approximately
6000 third stage larvae (L3) of one of the isolates and faeces were
collected for egg recovery and larval cultures. For EHAs, only animals
with at least 500 eggs/g faeces (epg) were used. Animals were treated
orally with Cydectin 0.1% (0.2 mg/kg KGW) three weeks after begin of
patency to clear the infections.
Eggs were puriﬁed from fresh faeces using a sucrose step gradient.
Brieﬂy, faeces were homogenised and passed through a 100 μm sieve.
Eggs in the ﬂow through were collected on a 25 μm sieve followed by
centrifugation and ﬂotation with saturated sodium chloride solution.
Then, the egg suspension was laid on the top of a sucrose step gradient
containing 10%, 25% and 40% of a saturated sucrose solution and
centrifuged at 2000×g and 4 °C for 5 min. Eggs ﬂoated between the
10% and 25% layer. They were collected and washed with de-ionised
water.
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2.2. Egg hatch assay
Egg hatch assays (EHA) were principally carried out as described by
Demeler et al. (2012). Recovered eggs were suspended in sodium
phosphate buﬀer (10 mM NaPOi buﬀer, pH 7) and adjusted to ap-
proximately 100 eggs/ml. TBZ (Sigma-Aldrich, T8904) was dissolved at
a concentration of 10063 μg/ml in DMSO. From this stock solution,
working solutions were prepared by dilution with DMSO. Stock and
working solutions were prepared at least 24 h prior to use. Assays were
set-up in 24-well plates with each well consisting of 1990 μl of egg
suspension and 10 μl of drug solution or DMSO (vehicle control). A
dilution range with ﬁnal concentrations of 0.01, 0.024, 0.05, 0.077,
0.101, 0.157, 0.177, 0.201, 0.252 and 0.503 μg/ml of TBZ and positive
control of 5.0315 μg/ml TBZ were used in assays with the isolates HcH,
IRE and CAVR. For the highly resistant strains TBZ and WR, additional
ﬁnal concentrations of 0.75, 0.9, 1.0, 1.25 and 5.0315 μg/ml of TBZ and
a positive control of 50.315 μg/ml TBZ were used.
Plates were incubated for 48 h at 25–27 °C and stopped with a drop
of Lugol's iodine. All assays were performed at least in duplicate and
repeated ﬁve times independently. Eggs and larvae were counted and
the number of hatched larvae was calculated as percentage. EC50 values
were determined by four parameter logistic regression using GraphPad
Prism 5.0.3. Top constraints were restricted to values between 0 and
100% and bottom constraints were set to equal 0%.
Sums of square F tests were conducted to determine signiﬁcant
diﬀerences between isolates. All p values were corrected for multiple
testing using the Holm correction as implemented in the p.adjust
command in R statistics version 3.3.1.
2.3. DNA extraction and pyrosequencing of isotype 1 β-tubulin gene
Approximately 10,000 L3 of each isolate were concentrated using a
Baermann Apparatus and kept at 80 °C until usage. DNA was isolated
using the NucleoSpin Tissue XS kit (Macherey Nagel) according to
manufacturer's instructions. To improve DNA yield, samples were in-
itially thawed and homogenised in the presence of T1 Lysis Buﬀer
(Macherey Nagel) using the SpeedMill P12 and innuSPEED Lysis Tubes
F (both Analytik Jena) for three cycles of 1 min.
PCRs speciﬁc for H. contortus isotype 1 β-tubulin were run essen-
tially as described by Ademola et al. (2015) by setting up 50 μl reac-
tions containing 1 × HF Buﬀer, 1 U Phusion II High Fidelity DNA
polymerase (Thermo Scientiﬁc), 0.2 mM dNTPs, 0.25 μM of each
primer (HcPY2PCRFor: 5′-GACGCATTCACTTGGAGGAG-3′ and
HcPY2PCRRev: 5′-Biotin-CATAGGTTGGATTTGTGAGTT-3′) and 2 μl of
DNA (ca. 10 ng). Cycling conditions were as follows: initial denatura-
tion at 98 °C for 30 s was followed by 40 cycles of 98 °C for 10 s, 56 °C
for 30 s and 72 °C for 30 s. PCRs were terminated by a ﬁnal elongation
at 72 °C for 10 min. PCR products were used as templates for the
subsequent pyrosequencing assays using the PyroMark Q24 system and
the PyroMark Gold Q24 kit following the manufacturer's instructions.
Sequencing primers used for measurement of allele frequencies were
Hc167PySeq1: (5′-ATAGAATTATGGCTTCGT-3′), Haemcon198Seq-Pr:
(5′-GGTAGAGAACACCGATG-3′), and Hc200PySeq1: (5′-TAGAGAACA-
CCGATGAAACAT-3′).
2.4. In vitro cultivation of third to fourth stage larvae
The in vitro protocol for cultivation of H. contortus was modiﬁed
from Rothwell and Sangster (1993) and Song (2003). Exsheathed L3s
were obtained by incubating 30 ml of L3 suspension with 1 ml of 12.5%
sodium hypochlorite for 10–15 min at 37 °C and 200 rpm. After mi-
croscopical control of exsheathment success, exsheathed L3 were wa-
shed twice with 0.9% NaCl solution by rapid mixing of larvae with
solution and removal of solution by ﬁltration through a bottle top
sterile ﬁlter collecting the larvae on the top of the ﬁlter. Then, larvae
were transferred to a Baermann Apparatus equipped with a 22 μm
precision-woven nylon mesh and containing 0.9% NaCl solution. After
incubation for at least 60 min, L3s were collected in a falcon tube and
ﬁlled up with pre-warmed (37.5 °C) sterile axenisation ﬂuid (136 mM
NaCl, 5 mM KCL, 0.05 mM NaH2PO4, 0.1 mM Na2HPO4, 2 mM glucose,
0.024 mg/ml benzylpenicillin, 0.064 mg/ml streptomycin and
0.0008 mg/ml amphotericin B). Exsheated L3s were kept in this ﬂuid at
37.5 °C and 90 rpm for 3 h. During this period, the axenisation ﬂuid was
replaced three times by removing the old solution by ﬁltration on a
bottle top ﬁlter.
Larvae were ﬁnally concentrated by ﬁltration and maintained in
pre-warmed RPMI 1460 culture medium (Lonza), supplemented with
20% foetal bovine serum (FBS) (Biochrom) and 0.06 mg/ml benzyl-
penicillin, 0.1 mg/ml streptomycin and 0.002 mg/ml amphotericin B,
at a density of approximately 2080 larvae per ml culture medium at
41 °C and 20% CO2 for 2 days. On day 3, culture medium was replaced
with fresh culture medium and larvae were incubated for another two
days until exposure to TBZ.
2.5. Thiabendazole exposure of fourth stage larvae
Larvae were microscopically controlled to ensure that at least 80%
had moulted to the L4 stage and displayed active pharynx pumping.
Then, larvae were split into three groups of approximately 100,000 L4s
each. Two groups were exposed to TBZ (0.5 μg/ml) for 3 h and 6 h,
respectively. One group served as vehicle control and was incubated
with 0.05% DMSO for 3 h. After incubation, L4s were washed with 4 °C
cold 0.9% NaCl solution via ﬁltration and collected in a falcon tube. L4s
were pelleted through centrifugation at 4 °C and maximum speed for
5 min, re-suspended in cold 0.9% NaCl solution and again pelleted. The
pellet was transferred to a lysis tube and frozen at −80 °C until used.
2.6. RNA extraction and cDNA synthesis
For optimal RNA isolation, larvae were rapidly thawed in the pre-
sence of T1 Lysis Buﬀer (Macherey Nagel) and homogenised using the
SpeedMill P12 and innuSPEED Lysis Tube F (Analytik Jena) for three
cycles of 1 min. The remaining steps were performed with the
NucleoSpin RNA kit from Macherey Nagel according to manufacturer's
instructions. Approximately 125 ng of RNA were treated with DNase I
(Thermo Fisher) and reverse transcribed to cDNA using Thermo Fisher's
Dynamo cDNA Synthesis Kit. For a 20 μl reaction mixture, 2 μl of M-
MuLV RNase H+ reverse transcriptase and 1 μl of random hexamers
were added to 10 μl RT buﬀer and RNA. cDNA was synthesised by in-
cubating the mixture at 25 °C for 10 min, followed by 39 °C for 30 min
and 85 °C for 5 min. Then, cDNA was diluted 1:3 and 1:6 for subsequent
expression analysis of CYP- and reference genes, respectively.
2.7. Quantitative reverse-transcription PCR
Reference genes superoxide dismutase (sod), fatty acid retinol
binding protein (far) and glyceraldehyde-3P-dehydrogenase (gpd) were
adopted from Lecova et al. (2015) who had shown stable expression of
these transcripts in adult H. contortus following varying treatments with
albendazole and ivermectin. Primer sequences of both reference and
candidate CYP genes can be found in Table S1 along with PCR eﬃ-
ciencies for each primer set. PCR reactions were run using the GoTaq
qPCR Master Mix (Promega) on the CFX96 real-time PCR cycler
(Biorad). A 50 μl reaction mixture was set up containing 25 μl of the
GoTaq qPCR Master Mix for Dye-Based Detection, 21 μl of nuclease-free
water, 0.2 μM of each primer and 2 μl of cDNA. Cycling conditions
included initial denaturation at 95 °C for 2 min, followed by 40 cycles of
95 °C for 15 s and 60 °C for 1 min. A melt curve was generated by
heating from 60 °C to 95 °C with increments of 0.5 °C each 5 s.
Samples were run in 2–5 biological and two technical replicates. All
real-time PCRs were performed twice independently and primer eﬃ-
cacies were evaluated in every run via ten-fold serial dilutions with
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plasmid DNA carrying the respective genes (4 × 108–- 4 × 101 copies).
Melt curves indicated absence of unspeciﬁc products. To account for
run-to-run variation, a pool of plasmid DNA was used as a calibrator on
each plate and data was analysed with the CFX™ Manager Software 2.0
which considers PCR eﬃciencies when calculating relative expression
levels (Pfaﬄ, 2001). Statistical analysis to compare the gene expression
level of target genes between treatment groups within one isolate and
between diﬀerent isolates without drug exposure was carried out using
the one-way ANOVA with Tukey's post hoc test in GraphPad Prism
5.0.3.
3. Results
3.1. Phenotypic resistance status of isolates against thiabendazole
determined by egg hatch assays
Phenotypic resistance towards TBZ was determined by calculating
EC50 values of all isolates. A wide range of EC50 values was found. For
the BZ-susceptible HcH and CAVR isolates, EC50 values of 0.018 and
0.024 μg/ml, respectively, were obtained. With an EC50 value of
0.96 μg/ml, the WR isolate displayed the highest resistance towards
TBZ. For the other two isolates of H. contortus, intermediate resistances
were determined (EC50 values of 0.118 and 0.189 μg/ml for IRE and
TBZ) (Fig. 1). The diﬀerence in EC50 values among all isolates were
statistically highly signiﬁcant (Table 1).
3.2. Frequency of benzimidazole-resistance associated single nucleotide
polymorphisms determined by pyrosequencing
The frequency of the resistance-associated TAC SNP at codon 200
was strongly elevated in the BZ-resistant isolates WR (93.5 ± 2%,
mean ± SD), TBZ (74.8 ± 2.7%) and IRE (64.5 ± 3.1%) compared
to the BZ-susceptible HcH and CAVR isolates with frequencies of
6 ± 0.9% and 10 ± 1.4%, respectively, which corresponded to the
technical background (Table 2). No evidence for increased frequencies
of resistance-associated alleles at codons 167 and 198 wasfound, which
is in agreement with previous results using the IRE and WR isolates
(von Samson-Himmelstjerna et al., 2009).
3.3. CYP expression in susceptible and resistant isolates of Haemonchus
contortus following thiabendazole exposure
Due to insuﬃcient in vitro development rates of L3 during the es-
tablishment phase of the cultivation method causing a limitation in
available number of L3 and, more importantly, very low yield of RNA
for some replicates, it was not possible to achieve ﬁve biological
replicates for all isolates and time points. Since the experiments re-
quired large numbers of larvae (100,000 per replicate) and the number
of available L3 was limited, no additional experiments were possible.
For most isolates and experimental conditions, at least four replicates
were available while only three were analysed for the IRE isolate and
the TBZ isolate after 3 h exposure to TBZ and only two for the TBZ
isolate after 6 h TBZ exposure.
Transcript levels of investigated CYPs in all isolates showed no
signiﬁcant changes following 3 or 6 h exposure to 0.5 μg/ml TBZ when
compared to worms of the corresponding isolate treated for 3 h with
DMSO alone (Figs. 2 and 3). However, only two biological replicates
were available for the resistant TBZ isolate at the 6 h time point, which
in case of CYP HCOI100383400, HCOI100383700 and HCOI01928800b
showed a high degree of variability.
3.4. Comparison of basal transcript levels between isolates in the absence of
drugs
Comparison of the basal transcript levels revealed no signiﬁcant
diﬀerences for HCOI100383700, HCOI01928800a, HCOI01928800b in
any of the isolates (Fig. 2B, C, D). In contrast, signiﬁcantly elevated
transcript levels were observed for HCOI100383400 in the highly TBZ
resistant WR isolate compared to both susceptible isolates, HcH (2.4-
fold) and CAVR (2.7-fold), and the intermediately resistant IRE (3.7-
fold) isolate (Fig. 2A). Transcript levels were slightly but not sig-
niﬁcantly elevated for the TBZ isolate. For HCOI01579500, transcript
levels were signiﬁcantly lower (approximately 5.7 fold) in the IRE and
WR isolates compared to the HcH isolate (Fig. 3). The IRE isolate dis-
played lower transcript levels for the other CYPs as well when com-
pared to the HcH isolate. However, these diﬀerences were not statisti-
cally signiﬁcant.
4. Discussion
Cytochrome P450 monooxygenases have several times been con-
sidered as players in the evolution of anthelmintic resistance. However,
the most convincing studies were conducted with C. elegans while
knowledge of CYPs present in parasitic nematodes is still very scarce.
For H. contortus, this has changed only recently, when Laing et al.
(2015) characterised its CYP superfamily and provided a basis to assay
speciﬁc CYPs. In the present study, ﬁve H. contortus isolates were
evaluated regarding their resistance status by EHAs and
Fig. 1. Concentration-response-curves for thiabendazole using diﬀerent Haemonchus
contortus isolates in an egg hatch assay. All EC50 values are signiﬁcantly diﬀerent from
each other with a p = 0.0009.
Table 1
Eﬃcacy of thiabendazole against Haemonchus contortus in an egg hatch assay.
Isolate EC50 [μg/ml]a 95% CI [μg/ml]b R2c
H.c Hannover 0.01809 0.01708–0.01916 0.9787
H.c CAVR 0.02434 0.02293–0.02584 0.986
H.c IRE 0.1186 0.1054–0.1335 0.9448
H.c TBZ 0.1891 0.1817–0.1967 0.9399
H.c WR 0.9637 0.5814–1.597 0.9889
a Eﬀective concentration 50%.
b 95% conﬁdence interval.
c Coeﬃcient of determination.
Table 2
Mean frequencies (in %) ± standard deviation of benzimidazole resistance-associated
alleles in the β-tubulin 1 gene.
Isolate Codon 200 (TAC) Codon 198 (GCA) Codon 167 (TAC)
H.c Hannover 6 ± 0.9 13.5 ± 1 5.5 ± 0.6
H.c CAVR 10 ± 1.4 15.5 ± 1.7 10 ± 1.8
H.c IRE 64.5 ± 3.1 14.3 ± 1.5 6.3 ± 2.1
H.c TBZ 74.8 ± 2.7 13.2 ± 1.5 11.7 ± 1.3
H.c WR 93.5 ± 2 14.7 ± 1.3 2.6 ± 0.6
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pyrosequencing assays targeting codons 200, 198 and 167 of the iso-
type 1 β-tubulin gene. Then, the constitutive and TBZ-inducible ex-
pression of HCOI100383700, HCOI01928800a, HCOI01928800b,
HCOI100383400 and HCOI01579500 were measured in L4 obtained by
in vitro culture. The ﬁrst four of the chosen CYPs are orthologues of the
BZ- and/or xenobiotic-inducible CYP34 and CYP35 families in C. ele-
gans while HCOI01579500 is an orthologue of the xenobiotic-inducible
CYP31 family. Therefore, all closest phylogenetic relatives to the xe-
nobiotic-inducible CYP families in the H. contortus genome have been
included in the present study.
In vertebrates, the CYP gene superfamily is known to include so-
called evolutionary stable and unstable genes. While stable CYP genes
are typically the only members in their CYP family, are evolutionary
conserved and function in biosynthesis and metabolism of endogenous
substrates, unstable CYP genes generally show a high rate of gene du-
plication and deletion and encode enzymes acting on xenobiotic sub-
strates (Thomas, 2007). The latter birth-death evolutionary scenario
has been proposed to apply also to the evolutionary history of CYP
genes in C. elegans (Thomas, 2007). Among the investigated H. contortus
CYPs, HCOI100383700, HCOI01928800a, HCOI01928800b and
HCOI100383400 all cluster in the same family, whereas HCOI0579500
appears to be a member of a CYP family containing no other members.
Consistent with the above interpretation, all CYPs from the CYP34/35
family are more highly expressed in the intestine of adult H. contortus
than in the soma (Laing et al., 2015). Since the intestine is hypothesised
to be the major site of detoxiﬁcation in nematodes (Lindblom and Dodd,
2006; McGhee, 2007; Rosa et al., 2015), this expression pattern would
be in agreement with a role in detoxiﬁcation.
Although exposure to TBZ did not induce a signiﬁcant change in
transcript level of any of the CYPs in the CYP34/35 family, basal ex-
pression of HCOI100383400 was signiﬁcantly elevated in the highly
resistant WR compared to the susceptible HcH, CAVR and the moder-
ately resistant IRE isolates. However, the rather small diﬀerence in
basal transcript level of this CYP in the resistant WR isolate suggests
Fig. 2. Expression levels of cytochrome P450 family 34/35 (Cyp34/35) mRNA orthologues in response to thiabendazole. Fourth stage larvae obtained by in vitro culture were exposed to
0.05% DMSO (vehicle control) for 3 h or 0.5 μg/ml thiabendazole (TBZ) in 0.05% DMSO for 3 or 6 h. Expression of the Cyps HCOI100383400 (A) HCOI100383700 (B), HCOI01928800a
(C), HCOI01928800b (D) was analysed using the housekeeping genes superoxide dismutase (sod), fatty acid retinol binding protein (far) and glyceraldehyde-3P-dehydrogenase (gpd) as
reference genes and the HcH isolate as control for normalisation.
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merely a minor role in resistance. For comparison, induction of
cyp35D1 by TBZ in C. elegans was 257-fold (1 h; 0.125 mM TBZ) and
thus considerably higher albeit at a 50-fold higher TBZ concentration.
Nevertheless, such a constitutive overexpression has the potential to
protect against the eﬀects of BZs at a very early time-point after ex-
posure whereas inducible expression should be assumed to take several
hours until enough functional enzyme has been synthesised to achieve
considerable protection.
In this context, it should be noted that the WR isolate is resistant to
IVM and also partially resistant to levamisole and increased expression
levels of HCOI100383400 might also be a result of selection by these
anthelmintics. However, in the absence of an inducibility by TBZ, in-
vestigations on potential eﬀects of other anthelmintics on transcript
levels and any functional data on drug binding or metabolism by
HCOI100383400, it is impossible to assess which explanations are more
likely. Another important aspect is that the isolates included in the
study have completely independent genetic backgrounds. Thus, ﬁnding
higher or lower expression level as for HCOI100383400 in WR and for
HCOI01579500 in IRE and WR isolates, respectively is in no way con-
clusive. Diﬀerences between isolates might simply be by chance and
completely independent of the resistance status.
The expression of the CYP31 orthologue HCOI01579500 is evi-
dently higher in the soma of H. contortus than in the intestine and
highest in adult females (Laing et al., 2015). Further, its C. elegans or-
thologues cyp31A2 and cyp31A3 are expressed in gonads and oocytes
and have been shown to be indispensable for proper development of the
embryo (Benenati et al., 2009). Even though there is no functional in-
formation available for HCOI01579500, the possibility of a similar
critical function in development in H. contortus should not be com-
pletely excluded. Similarly, a role in xenobiotic metabolism should not
be ruled out entirely, since CYPs may have activity against both en-
dogenous and xenobiotic substrates as implied by the inducibility of C.
elegans cyp31A by the xenobiotics PCB52, β-naphtoﬂavone, pheno-
barbital, atrazine, pyrazol and toluene (Menzel et al., 2001). Interest-
ingly, the IRE isolate showed lower transcript levels for the other CYPs
as well – all of which are expected to have exogenous substrates.
However, these diﬀerences were non-signiﬁcant which can most likely
be attributed to the small number of biological replicates that were
available for the IRE isolate since no other technical issues were en-
countered. In the absence of any known function of these CYP enzymes
and considering that most diﬀerences were not signiﬁcant it is not
possible to conclude if lower expression levels in the IRE isolate might
be physiologically relevant.
While the picture concerning the basal transcript levels of the ﬁve
CYPs in the L4 stage of these isolates is clear, the picture concerning
induced expression by TBZ is by far incomplete. The negative results
obtained in the present study do not exclude that induction of CYP
expression is possible under diﬀerent experimental conditions. For in-
stance, it cannot be excluded that an induction was not detected be-
cause up-regulation and return to basal levels might have occurred
outside of the 3–6 h time window used here. Alternatively, CYPs might
be responsive to TBZ in a concentration-dependent manner. Due to
limitations in the number of larvae that were available, it was not
possible to use a gradient of TBZ concentrations as previously done in
the case of C. elegans for diﬀerent albendazole concentrations (Laing
et al., 2010). Here, a concentration of 0.5 μg/ml TBZ was chosen as a
compromise aiming to use a concentration as high as possible while
ensuring that susceptible isolates survive for the incubation time. Apart
for a small number of individuals, larvae of both susceptible and re-
sistant isolates were alive until the moment of incubation termination
and the very few exceptions in all isolates most likely had no inﬂuence
on the outcome of the analysis. However, due to the wide range of
phenotypical BZ resistance within the ﬁve isolates, it might well be that
the concentration window needed for induced expression of CYPs dif-
fers between isolates and that this window was missed. Another po-
tential explanation for missing inducibility is the very artiﬁcial ex-
perimental setup. Since obtaining L4 in suﬃcient numbers from in vivo
experiments is extremely diﬃcult, in vitro culturing of L3 to L4 is a
reasonable alternative to study responses of parasitic life cycle stages.
Nevertheless, in vitro culture is a highly artiﬁcial system that might
have unpredictable eﬀects on the physiology of the L4s. Additionally, it
remains to be elucidated whether constitutive expression of these CYPs
is diﬀerent in adult worms or other larval stages and whether expres-
sion can be induced by TBZ in adults or after in vivo treatment of the
host.
Of course, the involvement of other CYPs that were not investigated
here is also possible. This would be particularly plausible for genes
belonging to rapidly evolving gene families with multiple members that
have relatively recently evolved by gene duplication (Laing et al.,
2015). This property again points to the four orthologues of the CYP34/
35 family, as revealed by the analysis presented by Laing et al. (2015).
Together, these data suggests that all members of rapidly evolving CYPs
in the H. contortus genome have been included here. Nevertheless, the
draft genome used to predict the H. contortus CYP gene family re-
presents 93% of the conserved eukaryotic genes (Laing et al., 2013).
Although this is a very good value for a nematode draft genome, the
missing 7% suggest that also some of CYP gene superfamily members
might have been missed.
In principle, mechanisms other than regulation of gene expression
might be involved. Genome sequence analysis suggests that unstable
vertebrate CYPs are subject to signiﬁcant positive selection for amino
acid changes possibly driven by xenobiotic substrates (Thomas, 2007).
Although highly speculative, such a mechanism might be present in H.
contortus or might eventually become relevant with the ongoing wide
use of BZs. However, it cannot be excluded that all the CYPs that were
investigated in the present study have no major function in xenobiotic
mechanism at all. All currently available information provides only
indirect arguments such as phylogenetic position, subfamily size and
tissue distribution while direct evidence such as induction by and in
particular metabolism of individual xenobiotics by particular CYPs is
still completely missing for H. contortus.
The frequency of the resistance-associated SNP in codon F200Y was
elevated in the phenotypically resistant IRE, TBZ and WR isolates. The
rank order of the EC50 values in the EHA and the frequency of the re-
sistance-associated SNP were identical over all ﬁve isolates in-
vestigated. This conﬁrms that the genotype of the isotype 1 β-tubulin
gene is the major parameter determining the BZ resistance status of H.
contortus. However, comparison of the three phenotypically resistant
Fig. 3. Expression levels of cytochrome P450 family 31 (Cyp31) mRNA orthologue in
response to thiabendazole. Fourth stage larvae obtained by in vitro culture were exposed
to 0.05% DMSO (for 3 h, vehicle control) or 0.5 μg/ml thiabendazole (TBZ) for 3 or 6 h.
Expression of the Cyp HCOI01579500 was analysed using the housekeeping genes su-
peroxide dismutase (sod), fatty acid retinol binding protein (far) and glyceraldehyde-3P-
dehydrogenase (gpd)as reference genes and the HcH isolate as control for normalisation.
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lines identiﬁes that a 10% increase in F200Y between the IRE (63.5%
F200Y) and TBZ (73.5% F200Y) isolates is associated with an increase
in the EC50 value by 1.6-fold. A further increase of the SNP frequency
by 19% (92.5% F200Y in WR) is accompanied by a further increase in
the EC50 value by 8.1-fold. Two phenomena might contribute to this
dramatic additional increase. First, the frequency of homozygous
worms carrying the allele associated with resistance is estimated to be
40.3% (IRE), 54.0% (TBZ) and 85.5% (WR) if random mating is as-
sumed. Considering the technical background of pyrosequencing, data
for the WR isolates do not even exclude that the isolate carries nearly
exclusively the resistant allele. Nevertheless, it is hard to imagine that
the dramatic increase in the EC50 value can be entirely attributed to
increased frequency in F200Y. von Samson-Himmelstjerna et al. (2009)
reported a F200Y frequency of 44% and an EC50 value in the EHA of
0.117 for the WR isolate. Since then, the isolate has gone through
several in vivo selections using albendazole. While comparing EHA EC50
values for TBZ with F200Y frequencies of several isolates, von Samson-
Himmelstjerna et al. (2009) identiﬁed eight isolates or ﬁeld samples
with F200Y frequencies between 90 and 100%. The EC50 values for
these H. contortus populations ranged between 0.13 and 0.66 μg TBZ/ml
– all lower than the WR isolate reported here. The high variability in
phenotypic resistance between isolates with 90–100% F200Y suggests
that selection at additional loci is able to further increase resistance
levels. These might involve the isotype 2 β-tubulin gene (Kwa et al.,
1993) but also other genes. If higher resistance levels are due to multi-
genic eﬀects, even moderate changes in constitutive expression of
several genes could have considerable additive or synergistic eﬀects on
the resistance phenotype. In such a multi-genic context, constitutive or
inducible overexpression of genes involved in detoxiﬁcation of anthel-
mintics might occur only in isolates with the highest resistance level
and diﬀerent isolates with high resistance might diﬀer in the set of
overexpressed genes.
In conclusion, the results of the present study do not provide clear
evidence that any of the H. contortus CYPs closely related to those in-
volved in metabolism of xenobiotics or speciﬁcally TBZ in C. elegans has
a role in resistance of the parasite. However, in combination with
previous EHA and pyrosequencing data, the results also clearly show
that (i) the isotype 1 β-tubulin gene locus cannot be the only one with
inﬂuence on the phenotypic resistance level and (ii) that the H. con-
tortus CYP gene HCOI100383400 should be considered as a candidate
that might be involved in very high-level BZ resistance in a multi-genic
context as well as in resistance to other anthelmintics.
Conﬂicts of interest
The authors declare no conﬂicts of interest.
Financial support
This work was ﬁnancially supported by grant GRK 2046 from the
German Research Foundation (DFG).
Appendix A. Supplementary data
Supplementary data related to this article can be found at http://dx.
doi.org/10.1016/j.ijpddr.2017.10.001.
References
Ademola, I.O., Krücken, J., Ramünke, S., Demeler, J., von Samson-Himmelstjerna, G.,
2015. Absence of detectable benzimidazole-resistance associated alleles in
Haemonchus placei in cattle in Nigeria revealed by pyrosequencing of beta-tubulin
isotype 1. Parasitol. Res. 114, 1997–2001.
AlGusbi, S., Krücken, J., Ramünke, S., von Samson-Himmelstjerna, G., Demeler, J., 2014.
Analysis of putative inhibitors of anthelmintic resistance mechanisms in cattle gas-
trointestinal nematodes. Int. J. Parasitol. 44, 647–658.
Barrett, J., 1998. Cytochrome P450 in parasitic protozoa and helminths. Comp. Biochem.
Physiol. C Pharmacol. Toxicol. Endocrinol. 121, 181–183.
Benenati, G., Penkov, S., Muller-Reichert, T., Entchev, E.V., Kurzchalia, T.V., 2009. Two
cytochrome P450s in Caenorhabditis elegans are essential for the organization of
eggshell, correct execution of meiosis and the polarization of embryo. Mech. Dev.
126, 382–393.
Blackhall, W.J., Prichard, R.K., Beech, R.N., 2008. P-glycoprotein selection in strains of
Haemonchus contortus resistant to benzimidazoles. Vet. Parasitol. 152, 101–107.
Cvilink, V., Skalova, L., Szotakova, B., Lamka, J., Kostiainen, R., Ketola, R.A., 2008. LC-
MS-MS identiﬁcation of albendazole and ﬂubendazole metabolites formed ex vivo by
Haemonchus contortus. Anal. Bioanal. Chem. 391, 337–343.
David, J.P., Ismail, H.M., Chandor-Proust, A., Paine, M.J., 2013. Role of cytochrome
P450s in insecticide resistance: impact on the control of mosquito-borne diseases and
use of insecticides on Earth. Philos. Trans. R. Soc. Lond B Biol. Sci. 368, 20120429.
David, M.A., Orlowski, S., Prichard, R.K., Hashem, S., Andre, F., Lespine, A., 2016. In
silico analysis of the binding of anthelmintics to Caenorhabditis elegans P-glycoprotein
1. Int. J. Parasitol. Drugs Drug Resist 6, 299–313.
Demeler, J., Kleinschmidt, N., Küttler, U., Koopmann, R., von Samson-Himmelstjerna, G.,
2012. Evaluation of the egg hatch assay and the larval migration inhibition assay to
detect anthelmintic resistance in cattle parasitic nematodes on farms. Parasitol. Int.
61, 614–618.
Demeler, J., Krüger, N., Krücken, J., von der Heyden, V.C., Ramünke, S., Küttler, U.,
Miltsch, S., Lopez Cepeda, M., Knox, M., Vercruysse, J., Geldhof, P., Harder, A., von
Samson-Himmelstjerna, G., 2013. Phylogenetic characterization of beta-tubulins and
development of pyrosequencing assays for benzimidazole resistance in cattle nema-
todes. PLoS One 8, e70212.
Elard, L., Humbert, J.F., 1999. Importance of the mutation of amino acid 200 of the
isotype 1 beta-tubulin gene in the benzimidazole resistance of the small-ruminant
parasite Teladorsagia circumcincta. Parasitol. Res. 85, 452–456.
Ghisi, M., Kaminsky, R., Maser, P., 2007. Phenotyping and genotyping of Haemonchus
contortus isolates reveals a new putative candidate mutation for benzimidazole re-
sistance in nematodes. Vet. Parasitol. 144, 313–320.
Grant, W.N., Mascord, L.J., 1996. Beta-tubulin gene polymorphism and benzimidazole
resistance in Trichostrongylus colubriformis. Int. J. Parasitol. 26, 71–77.
Janssen, I.J., Krücken, J., Demeler, J., Basiaga, M., Kornas, S., von Samson-
Himmelstjerna, G., 2013. Genetic variants and increased expression of Parascaris
equorum P-glycoprotein-11 in populations with decreased ivermectin susceptibility.
PLoS One 8, e61635.
Janssen, I.J., Krücken, J., Demeler, J., von Samson-Himmelstjerna, G., 2015.
Transgenically expressed Parascaris P-glycoprotein-11 can modulate ivermectin sus-
ceptibility in Caenorhabditis elegans. Int. J. Parasitol. Drugs Drug Resist 5, 44–47.
Jones, L.M., Flemming, A.J., Urwin, P.E., 2015. NHR-176 regulates cyp-35d1 to control
hydroxylation-dependent metabolism of thiabendazole in Caenorhabditis elegans.
Biochem. J. 466, 37–44.
Jones, L.M., Rayson, S.J., Flemming, A.J., Urwin, P.E., 2013. Adaptive and specialised
transcriptional responses to xenobiotic stress in Caenorhabditis elegans are regulated
by nuclear hormone receptors. PLoS One 8, e69956.
Kaschny, M., Demeler, J., Janssen, I.J., Kuzmina, T.A., Besognet, B., Kanellos, T.,
Kerboeuf, D., von Samson-Himmelstjerna, G., Krücken, J., 2015. Macrocyclic lactones
diﬀer in interaction with recombinant P-glycoprotein 9 of the parasitic nematode
Cylicocylus elongatus and ketoconazole in a yeast growth assay. PLoS Pathog. 11,
e1004781.
Kerboeuf, D., Guegnard, F., 2011. Anthelmintics are substrates and activators of nema-
tode P glycoprotein. Antimicrob. Agents Chemother. 55, 2224–2232.
Kotze, A.C., 1997. Cytochrome P450 monooxygenase activity in Haemonchus contortus
(Nematoda). Int. J. Parasitol. 27, 33–40.
Kotze, A.C., Hunt, P.W., Skuce, P., von Samson-Himmelstjerna, G., Martin, R.J., Sager, H.,
Krücken, J., Hodgkinson, J., Lespine, A., Jex, A.R., Gilleard, J.S., Beech, R.N.,
Wolstenholme, A.J., Demeler, J., Robertson, A.P., Charvet, C.L., Neveu, C., Kaminsky,
R., Rufener, L., Alberich, M., Menez, C., Prichard, R.K., 2014. Recent advances in
candidate-gene and whole-genome approaches to the discovery of anthelmintic re-
sistance markers and the description of drug/receptor interactions. Int. J. Parasitol.
Drugs Drug Resist 4, 164–184.
Krücken, J., Fraundorfer, K., Mugisha, J.C., Ramünke, S., Siﬀt, K.C., Geus, D., Habarugira,
F., Ndoli, J., Sendegeya, A., Mukampunga, C., Bayingana, C., Aebischer, T., Demeler,
J., Gahutu, J.B., Mockenhaupt, F.P., von Samson-Himmelstjerna, G., 2017. Reduced
eﬃcacy of albendazole against Ascaris lumbricoides in Rwandan schoolchildren. Int. J.
Parasitol. Drugs Drug Resist 7, 262–271.
Kwa, M.S., Kooyman, F.N., Boersema, J.H., Roos, M.H., 1993. Eﬀect of selection for
benzimidazole resistance in Haemonchus contortus on beta-tubulin isotype 1 and
isotype 2 genes. Biochem. Biophys. Res. Commun. 191, 413–419.
Kwa, M.S., Veenstra, J.G., Roos, M.H., 1994. Benzimidazole resistance in Haemonchus
contortus is correlated with a conserved mutation at amino acid 200 in beta-tubulin
isotype 1. Mol. Biochem. Parasitol. 63, 299–303.
Laing, R., Bartley, D.J., Morrison, A.A., Rezansoﬀ, A., Martinelli, A., Laing, S.T., Gilleard,
J.S., 2015. The cytochrome P450 family in the parasitic nematode Haemonchus
contortus. Int. J. Parasitol. 45, 243–251.
Laing, R., Kikuchi, T., Martinelli, A., Tsai, I.J., Beech, R.N., Redman, E., Holroyd, N.,
Bartley, D.J., Beasley, H., Britton, C., Curran, D., Devaney, E., Gilabert, A., Hunt, M.,
Jackson, F., Johnston, S.L., Kryukov, I., Li, K., Morrison, A.A., Reid, A.J., Sargison, N.,
Saunders, G.I., Wasmuth, J.D., Wolstenholme, A., Berriman, M., Gilleard, J.S.,
Cotton, J.A., 2013. The genome and transcriptome of Haemonchus contortus, a key
model parasite for drug and vaccine discovery. Genome Biol. 14, R88.
Laing, S.T., Ivens, A., Laing, R., Ravikumar, S., Butler, V., Woods, D.J., Gilleard, J.S.,
2010. Characterization of the xenobiotic response of Caenorhabditis elegans to the
anthelmintic drug albendazole and the identiﬁcation of novel drug glucoside meta-
bolites. Biochem. J. 432, 505–514.
E. Yilmaz et al. IJP: Drugs and Drug Resistance 7 (2017) 362–369
368
Lecova, L., Ruzickova, M., Laing, R., Vogel, H., Szotakova, B., Prchal, L., Lamka, J.,
Vokral, I., Skalova, L., Matouskova, P., 2015. Reliable reference gene selection for
quantitative real time PCR in Haemonchus contortus. Mol. Biochem. Parasitol. 201,
123–127.
Lindblom, T.H., Dodd, A.K., 2006. Xenobiotic detoxiﬁcation in the nematode
Caenorhabditis elegans. J. Exp. Zool. A Comp. Exp. Biol. 305, 720–730.
McGhee, J.D., 2007. The C. elegans Intestine. WormBook. pp. 1–36.
Menzel, R., Bogaert, T., Achazi, R., 2001. A systematic gene expression screen of
Caenorhabditis elegans cytochrome P450 genes reveals CYP35 as strongly xenobiotic
inducible. Arch. Biochem. Biophys. 395, 158–168.
Menzel, R., Rodel, M., Kulas, J., Steinberg, C.E., 2005. CYP35: xenobiotically induced
gene expression in the nematode Caenorhabditis elegans. Arch. Biochem. Biophys. 438,
93–102.
Munguia, B., Michelena, M., Melian, E., Saldana, J., Ures, X., Manta, E., Dominguez, L.,
2015. Development of novel valerolactam-benzimidazole hybrids anthelmintic deri-
vatives: diﬀusion and biotransformation studies in helminth parasites. Exp. Parasitol.
153, 75–80.
Perry, B.D., Randolph, T.F., MyDermott, J.J., Sones, K.R., Thornton, P.K., 2002. Investing
in Animal Health Research to Alleviate Poverty. ILRI, Nairobi, Kenya, pp. 148.
Peter, J.W., Chandrawathani, P., 2005. Haemonchus contortus: parasite problem No. 1
from tropics - polar Circle. Problems and prospects for control based on epide-
miology. Trop. Biomed. 22, 131–137.
Pfaﬄ, M.W., 2001. A new mathematical model for relative quantiﬁcation in real-time RT-
PCR. Nucleic Acids Res. 29, e45.
Prichard, R., 2001. Genetic variability following selection of Haemonchus contortus with
anthelmintics. Trends Parasitol. 17, 445–453.
Ramünke, S., Melville, L., Rinaldi, L., Hertzberg, H., de Waal, T., von Samson-
Himmelstjerna, G., Cringoli, G., Mavrot, F., Skuce, P., Krücken, J., Demeler, J., 2016.
Benzimidazole resistance survey for Haemonchus, Teladorsagia and Trichostrongylus in
three European countries using pyrosequencing including the development of new
assays for Trichostrongylus. Int. J. Parasitol. Drugs Drug Resist 6, 230–240.
Rochat, B., 2005. Role of cytochrome P450 activity in the fate of anticancer agents and in
drug resistance: focus on tamoxifen, paclitaxel and imatinib metabolism. Clin.
Pharmacokinet. 44, 349–366.
Rosa, B.A., Townsend, R., Jasmer, D.P., Mitreva, M., 2015. Functional and phylogenetic
characterization of proteins detected in various nematode intestinal compartments.
Mol. Cell Proteomics 14, 812–827.
Rothwell, J.T., Sangster, N.C., 1993. An in vitro assay utilising parasitic larval Haemonchus
contortus to detect resistance to closantel and other anthelmintics. Int. J. Parasitol. 23,
573–578.
Skuce, P., Stenhouse, L., Jackson, F., Hypsa, V., Gilleard, J., 2010. Benzimidazole re-
sistance allele haplotype diversity in United Kingdom isolates of Teladorsagia cir-
cumcincta supports a hypothesis of multiple origins of resistance by recurrent muta-
tion. Int. J. Parasitol. 40, 1247–1255.
Song, J., 2003. The Physiology and Pharmacology of Neurotransmitters and
Neuropeptides in Sheep Parasitic Nematodes. Faculty of Veterinary Science.
University of Sydney, Sydney.
Thomas, J.H., 2007. Rapid birth-death evolution speciﬁc to xenobiotic cytochrome P450
genes in vertebrates. PLoS Genet. 3, e67.
von Samson-Himmelstjerna, G., Blackhall, W.J., McCarthy, J.S., Skuce, P.J., 2007. Single
nucleotide polymorphism (SNP) markers for benzimidazole resistance in veterinary
nematodes. Parasitology 134, 1077–1086.
von Samson-Himmelstjerna, G., Walsh, T.K., Donnan, A.A., Carriere, S., Jackson, F.,
Skuce, P.J., Rohn, K., Wolstenholme, A.J., 2009. Molecular detection of benzimida-
zole resistance in Haemonchus contortus using real-time PCR and pyrosequencing.
Parasitology 136, 349–358.
E. Yilmaz et al. IJP: Drugs and Drug Resistance 7 (2017) 362–369
369
